Searchable abstracts of presentations at key conferences in endocrinology

ea0021p225 | Endocrine tumours and neoplasia | SFEBES2009

Mitotane treatment has profound effects on cortisol catabolism

Ghataore Lea , Abraha Hagosa , Chakraborti Indrani , Taylor Norman , Aylwin Simon , Schulte K-M

Mitotane (o,p’DDD) is an effective oral adrenolytic agent for treatment of advanced adrenocortical carcinoma (ACC). Inhibition of cortisol biosynthesis has been described. Cortisol metabolic clearance rate is unchanged, but decreased cortisol biovailability is indicated by increased dose requirement for hydrocortisone replacement during mitotane treatment. Urinary excretion of common cortisol metabolites (CM) has been reported to be normal but with increase of 6β-hyd...

ea0021p407 | Thyroid | SFEBES2009

Should the cytological finding of Thy 3 mandate surgical excision?

Chakraborti Indrani , Aylwin Simon , McGregor Alan , Schulte Klaus Martin , Diaz-Cano Salvador , Gilbert Jackie

Introduction: Current guidelines recommend that thyroid nodules classified as Thy 3 following fine needle aspiration (FNA) should be managed surgically. This results in over-treatment of benign disease. The purpose of this study was to review multi-disciplinary team (MDT) management of Thy 3 FNAs at our institution.Patients and methods: A total of 109 FNAs were performed between April 2008 and October 2009; 31 were reported as Thy 3. The management of al...